New micro­incision IOL yields promising results

The new Micro­incision Incise™ IOL™(Bausch and

Lomb)  provides good visual outcomes and  good

capsular stability, Antonio Toso  MD Bassiano

Hospital, Bassano del Grappa (VI), Italy  Italy, told the 18th ESCRS Winter Meeting in Ljubjana, Slovenia.

“The lens can be implanted through 1.8 mm in the

bag, providing excellent visual and refractive

outcomes," he said.

He presented the preliminary results achieved in

25 eyes of 25 patients implanted with the new lens

at his centre as part of a multicentre FDA trial. The

patients had a mean age was 72.0 years. All

underwent sub­2.0 2.0 MICS and implantation of

an Incise™ IOL through an 1.8 mm incision using

the Viscoject 1.5™ IOL inserter.

After a follow­up period ranging from four to six

months uncorrected visual acuity ranged from

20/32 to 20/25 and had a mean value of 0.156

logMAR. In addition, mean corrected distance

visual acuity was 20/20. Furthermore, mean

manifest refractive spherical equivalent  was ­0.28.

Furthermore, absolute total centration as measured

by digital slit lamp biomicroscopy was 0.29 mm,

statistically comparable with that achieved with

conventional one or three­piece IOLs, which

typically have a centration of 0.2 mm to 0.6 mm.

He noted that the Incise IOL is a one­piece lens is

composed of an enhanced hydrophilic material with

22 per cent water content. It has an aberration­free

sharp posterior edged optic with a diameter of 6.0

mm. Its overall length is of 11.0 mm. It has four

” told the 18th Congress of the ESCRS in

fenestrated angulated haptics.

He added that longterm results will be evaluated to

assess the posterior capsule opacification.

END